1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
GI Stool Testing Market 2015-2019 – Global Market Research

The Worldwide GI Stool Testing Sector: Forecast until 2019

  • September 2015
  • 61 pages
  • ID: 3287454
In this report:
The gastrointestinal stool testing market in the Americas was valued at $##.## million in 2014 and is expected to reach $##.## million by 2019, growing at CAGR of ##.##%.
The global gastrointestinal stool testing market was valued at $##.## million in 2014 and is expected to reach $##.## million by 2019, growing at CAGR of ##.##%.

Summary

Table of Contents

Search Inside

About GI stool testing

Normal gastrointestinal functioning is vitally for digestion as well as for the removal of body waste and pathogens. GI disorders are a frequent problem in the general population. These disorders are known to cause important harm to the health and quality of life of an individual. These disorders contain malabsorption disorders, inflammatory bowel diseases, cancer of the digestive system, colitis, and gastroenteritis. Globally, about 1.7-2 billion cases of diarrheal diseases occur every year. Also, about 1,700 million cases of C. difficile infections have been reported world-wide every year.

Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test and clinical microbiological stool tests. These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens including C. difficile, H. pylora, Rotavirus, and Adenovirus.

The overall GI stool testing sector is anticipated to grow at a compound annual growth rate (CAGR) of ~7.4 percent during 2014-2019.

What is the scope of this report?

In this business report, Technavio contains the current situation and growth expectations of the overall GI stool testing sector for 2015-2019. To calculate the market value, we examine revenue generated from the sales of the following products:

- FOBT

- Clinical microbiology stool test

The market study, World-wide GI Stool Testing Sector 2015-2019, has been produced established on a comprehensive and detailed market studies with data coming from specialists of the sector. The analysis includes the market landscape of the overall BI and analytics platform sector and its growth expectations in the upcoming years. This study also comprises a conversation established with top vendors operating in this segment.

Key areas

- Americas

- Asia-Pac

- Europe, Middle East and Africa (EMEA)

Main vendors

Other main sellers

Main market driver

- Increased incidence of C. difficile infections

- For a full, in-depth list, view our market report

Main market opportunity

- Accurate diagnostic testing

- For a full, exhaustive list, view our market report

Key market trend

- Focus on quick and early diagnosis

- For a full, in-depth list, view our market report

What are the main questions answered?

- What will both market value and growth rate be in 2019?

- What are the key market forecasts?

- What is driving this sector?

- What are the conditions to market growth?

- Who are the main sellers in this market environment?

- What are the opportunities in this industry and segment risks faced by the main vendors?

- What are the forces and weaknesses of the main vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Veterinary/Animal Vaccines Market by Type, Disease, Technology - Global Forecast to 2022

Veterinary/Animal Vaccines Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of ...

Global Cholera Vaccines Market 2018-2022

Cholera Vaccines Sector: Worldwide Forecast until 2022

  • $ 3500
  • Industry report
  • December 2017
  • by Infiniti Research Limited

About Cholera VaccinesThe cholera vaccines market appears to be concentrated due to the presence of few established players. The major vendors in the market compete based on pricing and presence across ...

Global Pneumonia Therapeutics Market 2017-2021

Pneumonia Therapeutics Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • November 2017
  • by Infiniti Research Limited

About Pneumonia TherapeuticsPneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. Pneumonia therapeutics market encompasses drugs and ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.